Noninvasive serum steroid signatures of lateralization and coexisting cortisol excess in primary aldosteronism
The Journal of Clinical Endocrinology & Metabolism · 10.11.2026
DOI: 10.1210/clinem/dgag454 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 10.11.2026. Verfasst von Seung Shin Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Abstract (Originalsprache)
Introduction
Adrenal venous sampling (AVS) remains the gold standard for primary aldosteronism (PA) subtyping but is invasive and technically demanding. We investigated whether peripheral steroid profiles could serve as a noninvasive tool for PA subtyping, characterizing the presence of coexisting mild autonomous cortisol secretion (MACS), and predicting biochemical outcomes after adrenalectomy.
Methods
In total, 216 patients with PA who underwent AVS between 2018 and 2022 were enrolled. Serum steroid profiling quantified 19 adrenal steroids and 17 metabolic ratios using liquid chromatography-mass spectrometry. Feature selection was performed using random forest–based recursive feature elimination. Logistic regression models were developed to predict lateralized PA and postoperative biochemical outcomes. Model performance was evaluated using receiver operating characteristic analysis.
Results
Lateralized PA showed significantly higher aldosterone and 18-hydroxycortisol (18-OHF) (P<0.001) but lower 11-hydroxyandrostenedione (11-OHA4) (P=0.001) than bilateral PA. A three-steroid model (18-OHF, aldosterone, 11-OHA4) showed discrimination comparable to a clinical model based on serum potassium, plasma aldosterone concentration, and plasma renin activity (AUC 0.821 vs. 0.790; P=0.351). A combined model integrating the clinical parameters with 18-OHF and 11-OHA4 achieved the highest performance (AUC 0.852), significantly outperforming the clinical model (P=0.002). Patients with lateralized PA and MACS had higher 18-OHF levels (age/sex-adjusted P=0.038). Baseline steroid markers were not significantly associated with post-surgical biochemical success (P>0.05).
Conclusion
Serum steroid profiling may facilitate the noninvasive identification of lateralized PA beyond clinical parameters alone. Coexisting MACS was associated with androgen suppression and altered steroid patterns, while the prognostic role of steroid profiles for treatment outcomes requires further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul, Republic of Korea.
- Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Doping Control Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.
ORCID-Profile: Kyu Eun Lee, Jung Hee Kim
Zitieren
APA
Park, S. S., Noh, J., Jung, S., Kim, S. J., Lee, K. E., Jung, K. C., Choi, M. H., & Kim, J. H. (2026). Noninvasive serum steroid signatures of lateralization and coexisting cortisol excess in primary aldosteronism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag454
Vancouver
Park SS, Noh J, Jung S, Kim SJ, Lee KE, Jung KC, et al. Noninvasive serum steroid signatures of lateralization and coexisting cortisol excess in primary aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag454
BibTeX
@article{Park2026,
author = {Park, Seung Shin and Noh, Jongsung and Jung, Sungyeon and Kim, Su-Jin and Lee, Kyu Eun and Jung, Kyeong Cheon and Choi, Man Ho and Kim, Jung Hee},
title = {Noninvasive serum steroid signatures of lateralization and coexisting cortisol excess in primary aldosteronism},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag454}
}
EUVIMED